Skip to main content

Animations

MJFF Publications

5941 - 5950 of 6514 Results
Title
Year
  • Year
  • 2016
  • 2019
  • 2020
  • 2023
  • 2022
  • 2016
  • 2025
  • 2024
  • 2024
  • 2026
  • Summary Details
    OPEN
    Title: Interview with Mark Frasier: A Michael J Fox Foundation Perspective on Precision Medicine in Parkinson’S
    Journal Name: Personalized Medicine
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.2217/pme-2016-0087
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Predicting Progression in Parkinson’s Disease Using Baseline and 1-Year Change Measures
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-181518
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Comparison of an Online-Only Parkinson’s Disease Research Cohort to Cohorts Assessed In Person
    Journal Name: Journal of Parkinson's Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-191808
    Citation Count: 28
  • Summary Details
    OPEN
    Title: Parkinson’s Progression Markers Initiative: A Milestone-Based Strategy to Monitor Parkinson’s Disease Progression
    Journal Name: Journal of Parkinson’s Disease
    Publisher: SAGE Publications
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.3233/jpd-223433
    Citation Count: 57
  • Summary Details
    OPEN
    Title: Nanostars Carrying Multifunctional Neurotrophic Dendrimers Protect Neurons in Preclinical In Vitro Models of Neurodegenerative Disorders
    Journal Name: ACS Applied Materials & Interfaces
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acsami.2c14220
    Citation Count: 23
  • Summary Details
    OPEN
    Title: Rare variants analysis of cutaneous malignant melanoma genes in Parkinson's disease
    Journal Name: Neurobiology of Aging
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2016.07.013
    Citation Count: 27
  • Summary Details
    OPEN
    Title: Oligogenic structure of amyotrophic lateral sclerosis has genetic testing, counselling and therapeutic implications
    Journal Name: Journal of Neurology, Neurosurgery & Psychiatry
    Publisher: BMJ
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1136/jnnp-2024-335364
    Citation Count: 12
  • Summary Details
    OPEN
    Title: Revised criteria for the diagnosis and staging of Alzheimer’s disease
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1038/s41591-024-02988-7
    Citation Count: 149
  • Summary Details
    OPEN
    Title: Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association Workgroup
    Journal Name: Alzheimer's & Dementia
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/alz.13859
    Citation Count: 1957
  • Summary Details
    OPEN
    Title: Structural remodeling of the mitochondrial protein biogenesis machinery under proteostatic stress
    Journal Name: Science Advances
    Publisher: American Association for the Advancement of Science (AAAS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1126/sciadv.aed3579
    Citation Count: 0
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.